U.S. Attorney warns of gainsharing risks
This article was originally published in The Gray Sheet
Executive Summary
U.S. Attorney James Sheehan warns that gainsharing is "fraught with risk" stemming from the implications of the anti-kickback statute and the Stark law in such arrangements. At the Medical Device Regulatory and Compliance Congress in Cambridge, Mass. on March 29, Sheehan advised device companies to proceed with caution as they move beyond the gainsharing demonstration project called for in the Deficit Reduction Act of 2005. The demonstration project allows physicians to share in hospital cost savings if they agree to follow certain cost-cutting measures, such as using specific products for which hospitals have negotiated lower prices (1"The Gray Sheet" Jan. 2, 2006, p. 10)...
You may also be interested in...
Gainsharing Demo Program, Medicare Imaging Cuts Included In Budget Bill
The House and Senate passed a deficit reduction bill that would authorize a gainsharing demonstration program at up to six sites beginning in 2007
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.